These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2327785)

  • 1. In vitro activity of amikacin against Mycobacterium avium.
    Inderlied CB
    Antimicrob Agents Chemother; 1990 Feb; 34(2):378-9. PubMed ID: 2327785
    [No Abstract]   [Full Text] [Related]  

  • 2. Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.
    Bermudez LE; Wu M; Young LS; Inderlied CB
    J Infect Dis; 1992 Oct; 166(4):923-6. PubMed ID: 1445599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing primary and secondary resistance to clarithromycin and amikacin in infections due to Mycobacterium avium complex.
    Renvoisé A; Brossier F; Galati E; Veziris N; Sougakoff W; Aubry A; Robert J; Cambau E; Jarlier V; Bernard C
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7153-5. PubMed ID: 26324275
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of free and liposome encapsulated amikacin on the survival of Mycobacterium avium complex in mouse peritoneal macrophages.
    Kesavalu L; Goldstein JA; Debs RJ; Düzgünes N; Gangadharam PR
    Tubercle; 1990 Sep; 71(3):215-7. PubMed ID: 2238129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of clofazimine alone and in combination with amikacin, roxithromycin, rifampicin and rifapentine against Mycobacterium avium-intracellulare].
    Casal Román M; Rodríguez López F; Villalba Montoro R; González Requero AI
    Enferm Infecc Microbiol Clin; 1989 Oct; 7(8):432-5. PubMed ID: 2490859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activity of oxazolidinones against Mycobacterium avium complex.
    Peters J; Kondo KL; Lee RK; Lin CK; Inderlied CB
    J Antimicrob Chemother; 1995 May; 35(5):675-9. PubMed ID: 7592181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare.
    Renvoisé A; Bernard C; Veziris N; Galati E; Jarlier V; Robert J
    J Clin Microbiol; 2014 Dec; 52(12):4439-40. PubMed ID: 25274991
    [No Abstract]   [Full Text] [Related]  

  • 8. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
    Rastogi N; Goh KS; Bryskier A
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
    Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
    J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
    Fattorini L; Li B; Piersimoni C; Tortoli E; Xiao Y; Santoro C; Ricci ML; Orefici G
    Antimicrob Agents Chemother; 1995 Mar; 39(3):680-5. PubMed ID: 7793873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Antibiotic Approved for Refractory Mycobacterium Avium Complex.
    Aschenbrenner DS
    Am J Nurs; 2019 Jan; 119(1):26. PubMed ID: 30589698
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of CO2 generation (BACTEC) and viable-count methods to determine the postantibiotic effect of antimycobacterial agents against Mycobacterium avium complex.
    Zhanel GG; Saunders MH; Wolfe JN; Hoban DJ; Karlowsky JA; Kabani AM
    Antimicrob Agents Chemother; 1998 Jan; 42(1):184-7. PubMed ID: 9449284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro synergistic effect between clarithromycin or azithromycin in combination with amikacin against Mycobacterium intracellulare.
    Zhang Z; Lu J; Du Y; Xie F; Wang Y; Sun B; Pang Y
    J Glob Antimicrob Resist; 2019 Sep; 18():183-186. PubMed ID: 30953831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide cultures.
    Ollar RA; Brown S; Dale JW; Felder MS; Brown IN; Edwards FF; Armstrong D
    Tubercle; 1991 Sep; 72(3):198-205. PubMed ID: 1663284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex.
    Inderlied CB; Lancero MG; Young LS
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():85-99. PubMed ID: 2808217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacteriostatic and bactericidal study of rifabutine and clofazimine in combination against Mycobacterium avium-intracellulare and Mycobacterium xenopi].
    Gevaudan MJ; Mallet MN; Bollet C; Gulian C; de Micco P
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):585-90. PubMed ID: 2552379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.
    Bermudez LE; Young LS
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1149-53. PubMed ID: 2847644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.